EMD
Click for more information
12.2% 4.6¢ emyria limited

Ann: Further positive MDMA analogue screening results received

  1. ASX News
    lightbulb Created with Sketch. 851
    clock Created with Sketch.
    10/05/22
    08:58
    Post #: 61304131
    Likes Created with Sketch. 19  Upvote
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

3DP Pointerra wins US$1.63M from US Dept of Energy to model climate change scenarios
right-arrow Created with Sketch.
AVA Ava Risk Group expands US presence with A$0.7M Substation Deal
right-arrow Created with Sketch.
LRV Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%
right-arrow Created with Sketch.
EX1 Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first
right-arrow Created with Sketch.
EMD Emyria and UWA secure $499,411 grant to advance MDMA analogue drug program
right-arrow Created with Sketch.
NEWS Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom
right-arrow Created with Sketch.
watchlist Created with Sketch. Add EMD (ASX) to my watchlist
(20min delay)
Last
4.6¢ 		Change
0.005(12.2%) 		Mkt cap ! $18.81M
Open High Low Value Volume
4.2¢ 4.8¢ 4.2¢ $6.128K 133.8K

Buyers (Bids)

No. Vol. Price($)
1 2500 4.4¢
 

Sellers (Offers)

Price($) Vol. No.
4.6¢ 24322 1
View Market Depth
Last trade - 16.10pm 01/07/2024 (20 minute delay) ?
EMD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.